Taki, H.; Kanazawa, T.; Akiyama, F.; Takashima, Y.; Okada, H.
Intranasal Delivery of Camptothecin-Loaded Tat-Modified Nanomicells for Treatment of Intracranial Brain Tumors. Pharmaceuticals 2012, 5, 1092-1102.
https://doi.org/10.3390/ph5101092
AMA Style
Taki H, Kanazawa T, Akiyama F, Takashima Y, Okada H.
Intranasal Delivery of Camptothecin-Loaded Tat-Modified Nanomicells for Treatment of Intracranial Brain Tumors. Pharmaceuticals. 2012; 5(10):1092-1102.
https://doi.org/10.3390/ph5101092
Chicago/Turabian Style
Taki, Hiroyuki, Takanori Kanazawa, Fuminari Akiyama, Yuuki Takashima, and Hiroaki Okada.
2012. "Intranasal Delivery of Camptothecin-Loaded Tat-Modified Nanomicells for Treatment of Intracranial Brain Tumors" Pharmaceuticals 5, no. 10: 1092-1102.
https://doi.org/10.3390/ph5101092
APA Style
Taki, H., Kanazawa, T., Akiyama, F., Takashima, Y., & Okada, H.
(2012). Intranasal Delivery of Camptothecin-Loaded Tat-Modified Nanomicells for Treatment of Intracranial Brain Tumors. Pharmaceuticals, 5(10), 1092-1102.
https://doi.org/10.3390/ph5101092